← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

EVP and Chief Commercial Officer Erik Harris sold $256K of Ultragenyx Pharmaceutical Inc.

Sold$256,328
$53.76Price
4,768Shares
−7%Stake

What RARE did after the filing

Filed Mar 5Copier in Mar 6
The stock from Wed, Mar 6 open, $51.42
−15.6%
S&P 500, same days
−1.9%

Measured over 30 trading days, to the Apr 18 close.

Traded Fri, Mar 1. Filed Tue, Mar 5, 8:08 PM ET, after the close. Returns use the Mar 6 open and the Apr 18 close. Not investment advice.